TOPICAL CORTICOSTEROIDS BIOEQUIVALENCE TEST METHODOLOGY IS UNDER REVIEW BY FDA; TWO STUDIES BY SAN DIEGO RESEARCHER STOUGHTON SHOW BRAND/GENERIC DIFFERENCES